According to researchers at Cleveland Hospital in the U.S. on the 6th, a way to prevent dementia was opened with "Viagra," a treatment for erectile dysfunction. It has been found that Viagra's "sildenafil" ingredient is effective as a treatment for dementia. The researchers analyzed the data of 7 million patients and confirmed that taking sildenafil had a 69% lower risk of developing dementia.
This study resonated greatly. This is because there is a high possibility of treating dementia called incurable diseases. However, this is not the first time research has been conducted on dementia treatment using Viagra. There is a domestic bio company that developed a treatment for dementia using Viagra two years earlier than a recent study. It is NeuroLive (CEO Lee Seok-chan), a new drug development venture company. The company will conduct clinical trials in January 2022 as a treatment for dementia using Viagra. It's faster than the United States.
NeuroLive has established a system that can reduce the time to develop new drugs and the risk of clinical failure by utilizing its own drug screening platform technology. Currently, nine patents have been applied at home and abroad for pipelines including Viagra-related dementia treatments. It was also selected as a baby unicorn selected by the Ministry of SMEs and Startups two years after its foundation.
Lee Seok-chan, CEO of NeuroLive, said, "Developing a treatment for central neurological diseases is a difficult and difficult path," adding, "But now domestic neuroscience is also at a global level." He added, "As the development of new drugs continues to develop, it can reach the world level soon," adding, "In particular, NeuroLive, which brings together people who enjoy neuroscience and new drug development, will grow into a representative."
Meanwhile, Lee Seok-chan, CEO of NeuroLive, majored in neuroscience as a bachelor's degree and doctorate course at the Korea Institute of Science and Technology (KIST) and Seoul National University Medical School, respectively. KIST and others have been studying brain neurological diseases such as depression and dementia for 25 years. In particular, he published a paper in Nature and was highly regarded for the possibility of treating degenerative brain diseases, ranking first in the 2020 best study.
Park sae-rom Reporter (tofha0814@mt.co.kr)
URL : http://naver.me/x4HXAd2Z
Comentários